C - Chemistry – Metallurgy – 07 – F
Patent
C - Chemistry, Metallurgy
07
F
260/325.1, 260/4
C07F 9/572 (2006.01) C07F 9/32 (2006.01)
Patent
CA 2032900
An increase in the diastereoselectivity resulting from the reaction of a phosphinic acid ester of the formula (see formula I) with the halo ester of the formula (see formula II) is achieved by carrying out the reaction in the presence of 4-methylmorpholine, diazabicyclooctane, quinuclidine, 1-methylpyrolidine, or cinchonidine. After removal of the R3 protecting group and fractional crystallization, the resulting desired diastereomeric pair can be resolved, and the desired isomer can be coupled to 4-substituted L-proline to give compounds possessing angiotensin converting enzyme inhibition activity. In particular, the process is useful in producing the antihypertensive agent fosinopril sodium in increased yields.
E.r. Squibb & Sons Inc.
Osler Hoskin & Harcourt Llp
LandOfFree
The diastereoselective preparation of phosphinate esters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with The diastereoselective preparation of phosphinate esters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The diastereoselective preparation of phosphinate esters will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1751936